AUGUST, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,513,028 | Use of MLN51 gene and protein | Creagene Inc. | 20-Aug-13 | Korea |
8,518,669 | Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase | Amano Enzyme Inc. | 27-Aug-13 | Japan |
8,507,248 | Genetically engineered biological indicator | American Sterilizer Company | 13-Aug-13 | United States |
8,507,217 | Ethanol yield and reduction of biomass accumulation in the recombinant strain of Saccharomyces cerevisiae overexpressing atpase | Archer Daniels Midland Company | 13-Aug-13 | United States |
8,501,447 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 6-Aug-13 | United States |
8,507,225 | Oligonucleotides for genotyping thymidylate synthase gene | F. Hoffmann-La Roche AG | 13-Aug-13 | Switzerland |
8,518,699 | Methods for genetic diversification in gene conversion active cells | GSF-Forschungszentrum fur Umwelt und Gesundheit, GmbH | 27-Aug-13 | Germany |
8,512,994 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Institut Pasteur | 20-Aug-13 | France |
8,512,993 | Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA | Institut Pasteur | 20-Aug-13 | France |
8,507,220 | Tobacco BY2 cells containing a tomato mosaic virus vector for protein production | Japan Science and Technology Agency | 13-Aug-13 | Japan |
8,501,431 | Method for screening for compounds selectively interacting with RAD9 | Magnachem International Laboratories, Inc. | 6-Aug-13 | United States |
8,501,413 | Methods and compositions for detecting a drug resistant EGFR mutant | Memorial-Sloan Kettering Cancer Center | 6-Aug-13 | United States |
8,518,650 | Biomarkers for prostate cancer and methods using the same | Metabolon, Inc. | 27-Aug-13 | United States |
8,518,687 | Cellulose hydrolase and gene thereof | National Pingtung University of Science and Technology | 27-Aug-13 | Taiwan |
8,512,944 | PRMT1 for target genes of cancer therapy and diagnosis | OncoTherapy Science, Inc. | 20-Aug-13 | Japan |
8,501,464 | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof | Ospedale San Raffaele S.r.l | 6-Aug-13 | Italy |
8,501,433 | Solvent for chromogenic substrate solution | Pierce Biotechnology, Inc. | 6-Aug-13 | United States |
8,512,948 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Quest Diagnostics Investments Incorporated | 20-Aug-13 | United States |
8,513,000 | High-throughput cell transfection device and methods of using thereof | Rational Biotechnology, Inc. | 20-Aug-13 | United States |
8,507,265 | High-throughput cell transfection device and methods of using thereof | Rational Biotechnology, Inc. | 13-Aug-13 | United States |
8,518,701 | Methods and materials for producing transgenic artiodactyls | Recombinetics, Inc. | 27-Aug-13 | United States |
8,518,644 | Method of judging inflammatory disease by using single nucleotide polymorphism | Riken | 27-Aug-13 | Japan |
8,501,442 | Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis | Sofar SpA | 6-Aug-13 | Italy |
8,512,999 | Production of oil in microorganisms | Solazyme, Inc. | 20-Aug-13 | United States |
8,507,273 | Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof | The Brigham and Women's Hospital, Inc. | 13-Aug-13 | United States |
8,507,245 | Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents | The Hong Kong Polytechnic University | 13-Aug-13 | Hong Kong |
8,501,404 | Gnaq mutations in melanoma | The Regents of the University of California | 6-Aug-13 | United States |
8,513,005 | DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence | The United States of America as Represented by the Secretary of the Army | 20-Aug-13 | United States |
8,518,685 | Engineered nitrile hydratase-producing bacterium with amidase gene knocked-out, the construction and the use thereof | Tsinghua University | 27-Aug-13 | China P Rep |
8,507,250 | Methods and genetically engineered micro-organisms for the combined production of PDO, BDO and PHP by fermentation | Tsinghua University | 13-Aug-13 | China P Rep |
8,518,657 | Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides | Universite de Montreal | 27-Aug-13 | Canada |
8,518,698 | Method of promoting apoptosis of glioblastoma tumor cells | University of Central Florida Research Foundation, Inc. | 27-Aug-13 | United States |
8,501,401 | Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals | University of Saskatchewan | 6-Aug-13 | Canada |
8,512,957 | Toxicity typing using liver stem cells | Vistagen Therapeutics, Inc. | 20-Aug-13 | United States |
8,507,247 | Influenza A virus with attenuating mutations in NS2 protein | Wisconsin Alumni Research Foundation | 13-Aug-13 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,515,680 | Analysis of transcriptomic data using similarity based modeling | Venture Gain L.L.C. | 20-Aug-13 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,512,710 | Class of therapeutic protein based molecules | Ansun Biopharma, Inc. | 20-Aug-13 | United States |
8,507,445 | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer | Board of Regents, The University of Texas System | 13-Aug-13 | United States |
8,518,892 | Methods to treat symptoms of pathophysiology related to body mass | Board of Supervisors of Louisiana State University and Agricultural Mechanical College | 27-Aug-13 | United States |
8,507,553 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof | Daewoong Pharmaceutical Co., Ltd. | 13-Aug-13 | Korea |
8,501,706 | Duplex oligonucleotide complexes and methods for gene silencing by RNA interference | Dharmacon, Inc. | 6-Aug-13 | United States |
8,513,207 | Extended dicer substrate agents and methods for the specific inhibition of gene expression | Dicerna Pharmaceuticals, Inc. | 20-Aug-13 | United States |
8,506,948 | UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-.alpha.expressing tumor | Medipost Co., Ltd | 13-Aug-13 | Korea |
8,518,907 | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) | Merck Sharp & Dohme Corp. | 27-Aug-13 | United States |
8,507,458 | System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron | National University Corporation Tokyo Medical and Dental University | 13-Aug-13 | Japan |
8,518,392 | Promoter-regulated differentiation-dependent self-deleting cassette | Regeneron Pharmaceuticals, Inc. | 27-Aug-13 | United States |
8,513,233 | Pyrimidinyl-propionic acid derivatives and their use as PPAR agonists | Shanghai Institute of Materia Medica, CAS | 20-Aug-13 | China P Rep |
8,512,709 | Modified amyloid .beta. peptide | The Chemo-Sero-Therapeutic Research Institue | 20-Aug-13 | Japan |
8,501,812 | Therapeutic methods for type I diabetes | University of Massachusetts | 6-Aug-13 | United States |
8,507,433 | Cardioprotective effects of GHRH agonists | University of Miami | 13-Aug-13 | United States |
8,518,391 | Monocytes as a gene delivery vector for secreted proteins to treat Alzheimer'S disease | University of South Florida | 27-Aug-13 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,507,755 | Methods for altering the reactivity of plant cell walls | Bayer Cropscience N.V. | 13-Aug-13 | Belgium |
8,513,485 | Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag | Envoy Therapeutics, Inc. | 20-Aug-13 | United States |
8,519,225 | Identification and use of target genes for control of plant parasitic nematodes | Monsanto Technology LLC | 27-Aug-13 | United States |
8,513,491 | Dehydrin genes and promoters from coffee | Nestec S.A. | 20-Aug-13 | Switzerland |
8,502,018 | Methods of modifying eukaryotic cells | Regeneron Pharmaceuticals, Inc. | 6-Aug-13 | United States |
8,507,754 | Engineering lipids in vegetative tissues of plants | University of North Texas | 13-Aug-13 | United States |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,519,099 | Methods for production of proteins | Life Technologies Corporation | 27-Aug-13 | United States |
8,519,097 | Molecules for targeting compounds to various selected organs or tissues | Prosena Technologies B.V. | 27-Aug-13 | Netherlands |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,507,663 | Compositions and methods for inhibiting expression of CD274/PD-L1 gene | Alnylam Pharmaceuticals, Inc. | 13-Aug-13 | United States |
8,513,401 | Double stranded nucleic acid targeting low copy promoter-specific RNA | City of Hope | 20-Aug-13 | United States |
8,501,924 | Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof | Falini; Brunangelo | 6-Aug-13 | Italy |
8,513,403 | Modified siRNA molecules and uses thereof | Protiva Biotherapeutics, Inc. | 20-Aug-13 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.